Guanabenz acetate
CAS: 23256-50-0
Ref. 3D-FG39114
| 1g | A consultar | ||
| 2g | A consultar | ||
| 5g | A consultar | ||
| 10g | A consultar | ||
| 500mg | A consultar |
Informação sobre produto
- ((2,6-Dichlorobenzylidene)amino)guanidine acetate
- ((2,6-Dichlorobenzylidene)amino)guanidine monoacetate
- 1-(2,6-Dichlorobenzylideneamino)guanidine acetate
- 3-((2,6-Dichlorophenyl)methylene)carbazamidine monoacetate
- Br 750
- Guanabenz acetate [USAN:JAN]
- Guanabenz monoacetate
- Guanidine, ((2,6-dichlorobenzylidene)amino)-, monoacetate
- Hsdb 6535
- Hydrazinecarboximidamide, 2-((2,6-dichlorophenyl)methylene)-, monoacetate
- Ver mais sinónimos
- Hydrazinecarboximidamide, 2-[(2,6-dichlorophenyl)methylene]-, acetate (1:1)
- N''-[(1E)-(2,6-dichlorophenyl)methylidene]carbonohydrazonic diamide acetate
- N''-[(1Z)-(2,6-dichlorophenyl)methylidene]carbonohydrazonic diamide acetate
- N''-[(2,6-dichlorophenyl)methylidene]carbonohydrazonic diamide acetate
- Rexitene
- Tenelid
- Unii-443O19Gk1A
- WY 8678 acetate
- Wytens
- Wytensin
Guanabenz acetate is a pentobarbital drug that is used in the treatment of congestive heart failure. It has been shown to increase the glomerular filtration rate and decrease the level of plasma proteins, such as gamma-aminobutyric acid and sodium succinate. It also inhibits the uptake of fatty acids by liver cells. Guanabenz acetate has been shown to be effective in vivo treatment for autoimmune diseases, infectious diseases, and other conditions. This drug can be given orally without any absorption enhancer or polymer, which makes it an attractive alternative to pentobarbital sodium.
Propriedades químicas
Consulta técnica sobre: 3D-FG39114 Guanabenz acetate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
